Back
Aprea Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
24
APRE
Aprea Therapeutics, Inc.
Last Price:
$0.72
Seasonality Move:
-21.91%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is relatively stagnant and APRE is experiencing buying pressure, which is a positive indicator for future bullish movement.
Aprea Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.71 | Buy |
| 20-day SMA: | 0.75 | Sell |
| 50-day SMA: | 0.75 | Sell |
| 200-day SMA: | 1.24 | Sell |
| 8-day EMA: | 0.72 | Sell |
| 20-day EMA: | 0.74 | Sell |
| 50-day EMA: | 0.79 | Sell |
| 200-day EMA: | 1.28 | Sell |
Aprea Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 45.82 | Sell |
| Chaikin Money Flow: | 59440 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.7 - 0.86) | Sell |
| Bollinger Bands (100): | (0.71 - 1.07) | Sell |
Aprea Therapeutics, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Aprea Therapeutics, Inc. Stock
Is Aprea Therapeutics, Inc. Stock a Buy?
-
Aprea Therapeutics, Inc. share price is 0.72 while APRE 8-day simple moving average is 0.71, which is a Buy signal.
-
The stock price of APRE is 0.72 while Aprea Therapeutics, Inc. 20-day SMA is 0.75, which makes it a Sell.
-
Aprea Therapeutics, Inc. 50-day simple moving average is 0.75 while APRE share price is 0.72, making it a Sell technically.
-
APRE stock price is 0.72 and Aprea Therapeutics, Inc. 200-day simple moving average is 1.24, creating a Sell signal.
APRE Technical Analysis vs Fundamental Analysis
Sell
24
Aprea Therapeutics, Inc. (APRE)
is a Sell
Is Aprea Therapeutics, Inc. a Buy or a Sell?
-
Aprea Therapeutics, Inc. stock is rated a SellThe current Aprea Therapeutics, Inc. [APRE] share price is $0.72. The Score for APRE is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
Aprea Therapeutics, Inc. Stock Info
Market Cap:
8.4M
Price in USD:
0.72
Share Volume:
108.6K
Aprea Therapeutics, Inc. 52-Week Range
52-Week High:
2.22
52-Week Low:
0.55
Sell
24
Aprea Therapeutics, Inc. (APRE)
is a Sell
Aprea Therapeutics, Inc. Share Price Forecast
-
What is the Aprea Therapeutics, Inc. stock price today?The Aprea Therapeutics, Inc. stock price is 0.72 USD today.
-
Will APRE stock go up or go down?Aprea Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Aprea Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aprea Therapeutics, Inc. is overvalued.
Is Aprea Therapeutics, Inc. Stock a Buy?
-
Aprea Therapeutics, Inc. share price is 0.72 while APRE 8-day exponential moving average is 0.72, which is a Sell signal.
-
The stock price of APRE is 0.72 while Aprea Therapeutics, Inc. 20-day EMA is 0.74, which makes it a Sell.
-
Aprea Therapeutics, Inc. 50-day exponential moving average is 0.79 while APRE share price is 0.72, making it a Sell technically.
-
APRE stock price is 0.72 and Aprea Therapeutics, Inc. 200-day simple moving average is 1.28, creating a Sell signal.
Fundamental Analysis of Aprea Therapeutics, Inc.
Is Aprea Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.11 per share, and an increase next year of $0.15 per share.
Technical Analysis of Aprea Therapeutics, Inc.
Should I short Aprea Therapeutics, Inc. stock?
-
APRE Moving Average Covergence Divergence (MACD) indicator is -0.02, suggesting Aprea Therapeutics, Inc. is a Sell
-
Aprea Therapeutics, Inc. Relative Strength Index (RSI) is 45.82, which suggest Aprea Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Aprea Therapeutics, Inc. is (0.7 - 0.86), which suggest Aprea Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Aprea Therapeutics, Inc. is (0.71 - 1.07), which suggest Aprea Therapeutics, Inc. is a Sell
* Aprea Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.